Aspect Biosystems Announces US$20 Million Series A Financing

Written By Guest User
Aspect%2BBiosystems.jpg

Aspect Biosystems has announced a US$20 Million Series A financing round lead by Radical Ventures and including existing and new investors. Aspect will use the capital to advance multiple tissue therapeutic programs, expand its technology platform capabilities, and expand its team.

Guest User
Previous

VoxNeuro Announces Research Project with St. Joseph's Healthcare Hamilton
Next

Fusion Pharmaceuticals receives investment commitment of up to US$20M